Drug intelligence / Profile preview

chlorambucil + prednisone

Development stage
Unknown
Lead developer
GSK
Modality
Small Molecules
Administration
Oral
01

Overview

The combination of chlorambucil and prednisone is a chemotherapy regimen used primarily for treating various types of cancer, particularly hematological malignancies. This combination leverages the complementary mechanisms of these two drugs to achieve better therapeutic outcomes than either drug alone. ## Composition and Mechanism Chlorambucil is an alkylating agent that works by forming covalent bonds with nucleic acids, disrupting DNA strands and suppressing antibody production[1][3]. It belongs to the nitrogen mustard family of chemotherapy drugs and is cell cycle non-specific, being most effective during the resting phase of cell division[4]. Prednisone is a corticosteroid with anti-inflammatory and immunosuppressive properties. When combined with chlorambucil, it enhances the overall efficacy of the treatment regimen. ## Medical Uses The chlorambucil + prednisone combination is primarily used to treat: - **Chronic lymphocytic leukemia (CLL)**[1][6] - **Non-Hodgkin's lymphoma**[2][6] - **Hodgkin's disease**[2][6] - **Waldenström's macroglobulinemia**[5] In veterinary medicine, this combination is also used to treat lymphoma, inflammatory bowel disease, and immune-mediated disorders in dogs and cats[3][4]. ## Dosage and Administration The dosage regimen varies depending on the specific condition being treated: - For Waldenström's macroglobulinemia: chlorambucil (8 mg/m² daily) and prednisone (40 mg/m² daily) for 10 days every 6 weeks[5] - For chronic lymphocytic leukemia and non-Hodgkin's lymphoma: dosages are typically adjusted based on clinical response and hematologic parameters[5] The medication is usually administered orally, with chlorambucil often taken on an empty stomach[6]. ## Side Effects Common side effects include: - Hematologic effects: lymphopenia, neutropenia, and potential bone marrow suppression[5] - Gastrointestinal symptoms: nausea, vomiting (though less severe than with some other chemotherapy regimens)[2][4] - Increased susceptibility to infections due to immunosuppression[4] More serious but less common side effects include: - Seizures (particularly with high doses)[5] - Irreversible bone marrow damage (with high cumulative doses)[5] ## Advantages Over Other Regimens The chlorambucil + prednisone combination is often preferred over more aggressive chemotherapy regimens like MOPP (mechlorethamine, vincristine, procarbazine, prednisone) because it causes less severe side effects such as nausea, vomiting, hair loss, and neuropathy, which can improve patient compliance[2].

Other names
ChlVPP
02

Targets

GR (Glucocorticoid receptor)DNA

Beyond the preview

Go deeper on chlorambucil + prednisone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on chlorambucil + prednisone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call